I think its clear that the Doc whose organization is behind this trial tipped his hand; he did the exact opposite of distancing himself from this endevour.
Remember the Trial Docs requested the extension; think this guys org didnt approve it; and didnt ask the right questions first ? think his org isn't paying for it ?
Doc Fillit and ADDF have put themselves out there front running the stunning results.
All just my opinion
Think of PRAN as an oil exploration company
Currently drilling three prospects
Two have drilled to target depth and are logging; ALZ Dome, and HD Dome
PD Dome spudded but drilling pilot hole
ALZ Dome 1 Billion Barrel min according to size of structure
HD Dome 100 Million min
PD Dome 300 Million min
Company owns worldwide rights to proprietary drilling tools and technique that allows for drilling in difficult and hostile environments
All the surrounding acreage owned by company, its IP if you will
PRAN reminds me of ARCO and SOHIO etc on North Slope many years ago
Or All horizontal drillers combined today
Revenue streams easily in the Billions per year
Oh, and the drilling crews just requested longer hours and more wells, and nearly all signed up
Those darn patients in the extension trial may keep talking to their families and friends and their Docs. Shame !
Happy Holidays All
12-14 for right now
Expect old 52 week high of 13.18 to go after a little more resistance here
AACR results in late Oct etc should take us to 18-20 by year end
Then thinking Company should sell 2-3 million shares and raise 40-60 million
Then we are set for pivotal trials later in 2014-15
Market cap a year out maybe 600-800 million with repeat MDS results etc..
Say 35 per share
Think 2015-2016 60-80 per share
They are rolling into the extension trial while Docors and caregivers continue seeing benefit ib both groups
Next thing you know the bad Doctors will petition the FDA to halt the current trial and put everone on the darn stuff
Nobody showing any love for stock traders
Last trade yesterday was at 1.80
It was suppressed and reported late at 16.00.02
Check the T & S
While Wall Street plays silly games with the share price....
Patients continue rolling into extension trial as Doctors and caregivers observe benefit
Most of the fools now washed overboard during tempest in teapot over HD routine data collection issues
Fear and Greed
50 day MA just crossed up thru 200 MA
Real float now only a few million shares tops, and shorts are screwed
AACR data less than 30 days away
Webcast Friday @2pm
Market cap will double at least before any fund raise
I agree completely.
The Doctors would be unethical putting their patients thru the additional burden on them and their families unless they had already observed some patient benefit. No Futility Analysis was done on the trial itself , as it is not an efficacy trial, it is a biomarker trial I believe.
The statement that the Doctors showed "strong support" for the follow on open label trial extension was made by the Company CEO I believe, and speaks volumes.
Tanzi will be a Laureate for sure if this proves out
Dan Gold stated during presentation that the Company may present patient data at this conference on MEI 344
Dual Mtor regulator and ROS regulator.
Slides available on webcast archive
Stated Company is very excited about this compound
We have TWO drugs in the clinic and this one is not in the share price in my opinion
Market Cap should be 2X-3X greater
This Company does not sell widgets
This Company can PREDICT THE FUTURE
Whats that worth once everybody wakes up ?
Way too low
Worth many times this to Big Pharma
Cut drug development costs and time in half or better
Teva first of many
Worth even more to patient pool
Save Obamacare Billions per year